SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009051
Filing Date
2015-11-02
Accepted
2015-11-02 09:36:06
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-10q_20150930.htm 10-Q 4040927
2 EX-10.2 bmrn-ex102_235.htm EX-10.2 74004
3 EX-31.1 bmrn-ex311_6.htm EX-31.1 14737
4 EX-31.2 bmrn-ex312_8.htm EX-31.2 14805
5 EX-32.1 bmrn-ex321_7.htm EX-32.1 5809
  Complete submission text file 0001564590-15-009051.txt   16535140

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20150930.xml EX-101.INS 4820987
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20150930.xsd EX-101.SCH 66909
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20150930_cal.xml EX-101.CAL 107742
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20150930_def.xml EX-101.DEF 243137
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20150930_lab.xml EX-101.LAB 543318
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20150930_pre.xml EX-101.PRE 457500
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 151189558
SIC: 2834 Pharmaceutical Preparations